The significance of endothelin in platelet-activating factor-induced fetal growth restriction

Reproductive Sciences

Volumn 19, Issue 11, 2012, Pages 1175-1180

  Neerhof, Mark G ^a,b   Khan, Saira ^a   Synowiec, Sylvia ^a   Qu, Xiao Wu ^a   Thaete, Larry G ^a,b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Endothelin; fetal growth restriction; platelet activating factor; pregnancy; rat

Indexed keywords

ABT 546; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; MESSENGER RNA; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; FETUS WEIGHT; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA WEIGHT; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERUS;

ANIMALS; ENDOTHELIN-1; FEMALE; FETAL GROWTH RETARDATION; FETAL WEIGHT; GENE EXPRESSION; ORGAN SIZE; PLACENTA; PLATELET ACTIVATING FACTOR; PREGNANCY; PREGNANCY OUTCOME; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ENDOTHELIN A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84867501866     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112443875     Document Type: Article

References (32)

1. McIntire DD, Bloom SL, Casey BM, Leveno KJ. Birth weight in relation to morbidity and mortality among newborn infants. New Engl J Med. 1999 ; 340 (16). 1234-1238
2. Lackman F, Capewell V, Richardson B, daSilva O, Gagnon R. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol. 2001 ; 184 (5). 946-953
3. Bernstein IM, Horbar JD, Badger GJ, Ohlsson A, Golan A. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. Am J Obstet Gynecol. 2000 ; 182 (1 pt 1). 198-206
4. Marconi AM, Ronzoni S, Vailati S, Bozzetti P, Morabito A, Battaglia FC. Neonatal morbidity and mortality in intrauterine growth restricted (IUGR) pregnancies is predicated upon prenatal diagnosis of clinical severity. Reprod Sci. 2009 ; 16 (4). 373-379
5. Narchi H, Skinner A, Williams B. Small for gestational age neonates - are we missing some by only using standard population growth standards and does it matter?. J Matern Fetal Neonatal Med. 2010 ; 23 (1). 48-54
6. Hanahan DJ. Platelet activating factor: a biologically active phosphoglyceride. Annu Rev Biochem. 1986 ; 55: 483-509
7. Handley DA, Tomesch JC, Saunders RN. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI63-441. Thromb Haemost. 1986 ; 56 (1). 40-44
8. Snyder F. Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol. 1990 ; 259 (5 pt 1). C697 - C708
9. Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol. 1999 ; 127 (4). 969-979
10. Schramek H, Wang Y, Konieczkowski M, Simonson MS, Dunn MJ. Endothelin-1 stimulates cytosolic phospholipase A2 activity and gene expression in rat glomerular mesangial cells. Kidney Int. 1994 ; 46 (6). 1644-1652
11. Mustafa SB, Gandhi CR, Harvey SAK, Olson MS. Endothelin stimulates platelet-activating factor synthesis by cultured rat Kupffer cells. Hepatol. 1995 ; 21 (2). 545-553
12. Abdel-Latif AA, Zhang Y, Yousufzai SYK. Endothelin-1 stimulates the release of arachidonic acid and prostaglandins in rabbit iris sphincter smooth muscle: activation of phospholipase A2. Curr Eye Res. 1991 ; 10 (3). 259-265
13. Montero A, Rodriguez-Barbero A, López-Novoa JM. A role for platelet-activating factor in endothelin-1-induced rat mesangial cell proliferation. Eur J Pharmacol. 1993 ; 243 (3). 235-240
14. Filep JG, Fournier A, Földes-Filep I. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2. Br J Pharmacol. 1994 ; 112 (3). 963-971
15. Collado MP, Latorre E, Fernandez I, Aragones MD, Catalan RE. Endothelin-1 decreases ethanolamine plasmalogen levels and evokes PAF production in brain microvessels. Microvasc Res. 2003 ; 66 (3). 197-203
16. Yoshizumi M, Kurihara H, Morita T, et al. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun. 1990 ; 166 (1). 324-329
17. Clavijo LC, Carter MB, Matheson PJ, et al. Platelet-activating factor and bacteremia-induced pulmonary hypertension. J Surg Res. 2000 ; 88 (2). 173-180
18. Foitzik T, Hotz HG, Eibl G, Hotz B, Kirchengast M, Buhr HJ. Therapy for microcirculatory disorders in severe acute pancreatitis: effectiveness of platelet-activating factor receptor blockade vs. endothelin receptor blockade. J Gastrointest Surg. 1999 ; 3 (3). 244-251
19. Stammberger U, Carboni GL, Hillinger S, Schneiter D, Weder W, Schmid RA. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury. J Heart Lung Transplant. 1999 ; 18 (9). 862-868
20. King-VanVlack CE, Mewburn JD, Chapler CK, MacDonald PH. Hemodynamic and proinflammatory actions of endothelin-1 in guinea pig small intestine submucosal microcirculation. Am J Physiol Gastrointest Liver Physiol. 2003 ; 284 (6). G940 - G948
21. Getting SJ, Di Filippo C, Lam CW, Rossi F, D'Amico M. Investigation into the potential anti-inflammatory effects of endothelin antagonists in a murine model of experimental monosodium urate peritonitis. J Pharmacol Exp Ther. 2004 ; 310 (1). 90-97
22. Thaete LG, Neerhof MG, Jilling T, Caplan MS. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. J Soc Gynecol Investig. 2003 ; 10 (3). 145-150
23. Thaete LG, Neerhof MG. Endothelin and platelet-activating factor: Significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. Am J Obstet Gynecol. 2006 ; 194 (5). 1377-1383
24. Thaete LG, Neerhof MG, Caplan MS. Endothelin receptor A antagonism prevents hypoxia-induced intrauterine growth restriction in the rat. Am J Obstet Gynecol. 1997 ; 176 (1 pt 1). 73-76
25. Thaete LG, Neerhof MG, Silver RK. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats. J Soc Gynecol Investig. 2001 ; 8 (1). 18-23
26. Rowland BL, Vermillion ST, Roudebush WE. Elevated circulating concentrations of platelet activating factor in preeclampsia. Am J Obstet Gynecol. 2000 ; 183 (4). 930-932
27. Taylor RN, Varma M, Teng NNH, Roberts JM. Women with preeclampsia have higher plasma endothelin levels than women with normal pregnancies. J Clin Endocrinol Metab. 1990 ; 71 (6). 1675-1677
28. Nova A, Sibai BM, Barton JR, Mercer BM, Mitchell MD. Maternal plasma level of endothelin is increased in preeclampsia. Am J Obstet Gynecol. 1991 ; 165 (3). 724-727
29. Kraayenbrink AA, Dekker GA, van Kamp GJ, van Geijn HP. Endothelial vasoactive mediators in preeclampsia. Am J Obstet Gynecol. 1993 ; 169 (1). 160-165
30. Greenberg SG, Clark KE. Hemodynamic effects of platelet-activating factor in nonpregnant and pregnant sheep. Am J Physiol. 1999 ; 277 (4 pt 2). R996 - R1001
31. Shibamoto T, Liu W, Cui S, Zhang W, Takano H, Kurata Y. PAF, rather than histamine, participates in mouse anaphylactic hypotension. Pharmacol. 2008 ; 82 (2). 114-120
32. Matsubara T, Yasuda K, Johnston JM, et al. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. Biol Reprod. 1997 ; 56 (4). 885-890